Durvalumab with or Without Bevacizumab with Transarterial Chemoembolisation in Hepatocellular Carcinoma (EMERALD-1): a Multiregional, Randomised, Double-Blind, Placebo-Controlled, Phase 3 StudyBruno Sangro,Masatoshi Kudo,Joseph P. Erinjeri,Shukui Qin,Zhenggang Ren,Stephen L. Chan,Yasuaki Arai,Jeong Heo, Anh Mai, Jose Escobar, Yamil Alonso Lopez Chuken,Jung-Hwan Yoon, Won Young Tak, Valeriy V. Breder, Tanita Suttichaimongkol, Mohamed Bouattour,Shi-Ming Lin, Jean-Marie Peron, Quang T. Nguyen,Lunan Yan, Chang-Fang Chiu, Florinda A. Santos, Anil Veluvolu,Satheesh Chiradoni Thungappa, Marco Matos,Magdalena Zotkiewicz, Stephanie Udoye,John F. Kurland, Gordon J. Cohen, Riccardo LencioniLANCET（2025）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
